Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppression in liver transplantation.

M S Cattral1, L B Lilly, G A Levy

  • 1Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Seminars in Liver Disease
|February 24, 2001
PubMed
Summary

Preventing liver transplant rejection and reducing drug toxicity are key goals. New combination therapies aim to minimize patient morbidity while maintaining high survival rates after transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Combined lung-liver-pancreas transplantation in a recipient with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2017
Same author

Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Donor BMI >30 Is Not a Contraindication for Live Liver Donation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Area of Science:

  • Transplantation immunology
  • Pharmacology

Background:

  • Graft rejection prevention is critical in liver transplantation.
  • Current immunosuppressants improve survival but cause significant morbidity due to toxicity.
  • Acute rejection rates are low with modern immunosuppression.

Purpose of the Study:

  • To explore strategies for minimizing morbidity in liver transplant recipients.
  • To investigate combination drug therapies for immunosuppression.
  • To maintain excellent patient and graft survival rates.

Main Methods:

  • Review of current immunosuppressive drug regimens.
  • Analysis of drug-related morbidity in liver transplant patients.
  • Evaluation of potential combination therapies.

Related Experiment Videos

Main Results:

  • Immunosuppressive drug toxicity is a major source of post-transplant morbidity.
  • Combination therapies offer a potential strategy to reduce drug toxicity.
  • Maintaining high patient and graft survival is achievable with optimized immunosuppression.

Conclusions:

  • Reducing immunosuppressive drug toxicity is essential for improving outcomes in liver transplantation.
  • Combination drug therapies represent a promising approach to minimize morbidity.
  • Further research into optimized immunosuppression is warranted.